Sonire Therapeutics

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

Another company involved in using AI to repurpose failed drugs - as well as drugs that have already been approved - is BioXcel Therapeutics. Unlike Ignota, however, the company focuses on compounds that have already demonstrated safety in prior clinical trials, but have been discontinued by their developers for various other reasons.

A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO says can "understand the concept of time and how you change, from cradle to grave.

We recently published a list of AI Stocks Dominate Friday's Top 10 Performers. In this article, we are going to take a look at where SoundHound AI Inc. (NASDAQ:SOUN) stands against other AI stocks that dominate Friday's top performers.

Intuitive Surgical is investing heavily in AI, AR, leading to future profitability. Learn why ISRG stock may present a buying opportunity.

Scott Smith; Investor Relations; SoundHound AI Inc. Keyvan Mohajer; Chief Executive Officer, Director; SoundHound AI Inc. Nitesh Sharan; Chief Financial Officer; Sou

SimCare AI, founded by two University of Chicago dropouts, has secured $2 million in seed funding to expand its AI-driven healthcare simulation platform. The company's solution uses realistic AI patients to set a new clinical benchmark, cutting training time and cost while meeting strict accreditation standards.

Telescope Innovations Corp. (CSE:TELI) is leveraging its expertise to advance chemistry process development and crystallization optimization in pharmaceuticals, industrial chemicals, and critical minerals ・Telescope's Self-Driving Labs (SDLs) integrate AI,